Pseudoxanthoma elasticum - rare hereditary disease with coronary and organ calcifications (RCD code: I-2.A.0)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 2
Abstract
Background: Pseudoxanthoma elasticum is a rare hereditary disease with estimated prevalence of 1 in 25,000 to 1 in 100,000 with cutaneous lesions and organ calcifications.Methods and results: We report a case of a young female with a cutaneous manifestation of pseudoxanthoma elasticum. Calcium deposits were found in coronary arteries and major vessels as well as in the lung and liver by means of computer tomography (CT) assessment. No members of the family were found to have the disease, so it was considered a sporadic case.Conclusion: Exceeding rare this cutaneous disease is associated with organ and vessels calcifications and is worth knowing as a rare cause for calcium depositions in the coronary arteries and potential myocardial ischemia or myocardial infarction in the very young. JRCD 2013; 1 (2): 42–45Key words: pseudoxanthoma elasticum, coronary artery calcifications, cutaneous lesions, organ calcifications
Authors and Affiliations
Branimir Kanazirev, D Konstantinova, G Tomov, S Kovachev
Keywords
Related Articles
- EP ID EP245382
- DOI 10.20418/jrcd.vol1no2.82
- Views 112
- Downloads 0
Journal of Rare Cardiovascular Diseases: All that glitters is not gold. Randomized Controlled Trails versus real‑life patients: Challenges of a maturing Journal
Dear Readers,Is time friend or foe? No one has the right answer. With this issue, we are celebrating an important landmark in the Journal’s history. On this occasion, we have looked back at our first two years with a pin...
Evaluation of arterial stiffness in patients with coronary atherosclerosis, cardiac syndrome X and systemic lupus erythematosus (RCD code: I-3C.1)
Objectives: Arterial stiffness manifested by high pulse wave velocity (PWV) consists a risk factor of atherosclerosis and cardio-vascular complications. Systemic lupus erythematosus (SLE) is a generalized autoimmune dise...
Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of com...
Facilitating recognition and grouping the expertise in the main fields of rare cardiovascular diseases
Dear Friends and Colleagues, Dear Readers,We are pleased to deliver at your hands the second issue of your quarterly Journal of Rare Cardiovascular Diseases. The feedback we have received, after launching the Journal in...
JRCD: a means to improve standards of care in rare cardiovascular diseases
Dear Friends and Colleagues, Dear Readers, I hope you will not mind me starting this Editorial with addressing, at first, Friends and Colleagues. This reflects the spirit of our new Journal. Our Friends and Colleagues ha...